ID   ERCC1_HUMAN             Reviewed;         297 AA.
AC   P07992; B2RC01; B3KRR0; Q7Z7F5; Q96S40;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   28-JUN-2023, entry version 212.
DE   RecName: Full=DNA excision repair protein ERCC-1;
GN   Name=ERCC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2420469; DOI=10.1016/0092-8674(86)90014-0;
RA   van Duin M., de Wit J., Odijk H., Westerveld A., Yasui A., Koken M.H.M.,
RA   Hoeijmakers J.H.J., Bootsma D.;
RT   "Molecular characterization of the human excision repair gene ERCC-1: cDNA
RT   cloning and amino acid homology with the yeast DNA repair gene RAD10.";
RL   Cell 44:913-923(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3034490; DOI=10.1101/sqb.1986.051.01.012;
RA   Hoeijmakers J.H.J., van Duin M., Westerveld A., Yasui A., Bootsma D.;
RT   "Identification of DNA repair genes in the human genome.";
RL   Cold Spring Harb. Symp. Quant. Biol. 51:91-101(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9360634; DOI=10.1016/s1383-5726(97)00004-6;
RA   Yu J.J., Mu C.J., Lee K.B., Okamoto A., Reed E.L., Bostick-Bruton F.,
RA   Mitchell K.C., Reed E.;
RT   "A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and
RT   tumor tissues.";
RL   Mutat. Res. 382:13-20(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Hisatomi H., Nagao K., Ishikawa H., Yokoyama Y., Ishihara Y., Hikiji K.,
RA   Iizuka T.;
RT   "Human excision repair protein 1, transcript variant, mRNA.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-266.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   FUNCTION (ISOFORMS 1; 2; 3 AND 4), SUBCELLULAR LOCATION (ISOFORMS 1; 2; 3
RP   AND 4), AND SUBUNIT (ISOFORMS 1; 2; 3 AND 4).
RX   PubMed=24036546; DOI=10.4161/cc.26309;
RA   Friboulet L., Postel-Vinay S., Sourisseau T., Adam J., Stoclin A.,
RA   Ponsonnailles F., Dorvault N., Commo F., Saulnier P., Salome-Desmoulez S.,
RA   Pottier G., Andre F., Kroemer G., Soria J.C., Olaussen K.A.;
RT   "ERCC1 function in nuclear excision and interstrand crosslink repair
RT   pathways is mediated exclusively by the ERCC1-202 isoform.";
RL   Cell Cycle 12:3298-3306(2013).
RN   [13]
RP   ALTERNATIVE SPLICING.
RX   PubMed=23514287; DOI=10.1056/nejmoa1214271;
RA   Friboulet L., Olaussen K.A., Pignon J.P., Shepherd F.A., Tsao M.S.,
RA   Graziano S., Kratzke R., Douillard J.Y., Seymour L., Pirker R.,
RA   Filipits M., Andre F., Solary E., Ponsonnailles F., Robin A., Stoclin A.,
RA   Dorvault N., Commo F., Adam J., Vanhecke E., Saulnier P., Thomale J.,
RA   Le Chevalier T., Dunant A., Rousseau V., Le Teuff G., Brambilla E.,
RA   Soria J.C.;
RT   "ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.";
RL   N. Engl. J. Med. 368:1101-1110(2013).
RN   [14]
RP   INTERACTION WITH USP45 AND ERCC4, UBIQUITINATION, AND DEUBIQUITINATION BY
RP   USP45.
RX   PubMed=25538220; DOI=10.15252/embj.201489184;
RA   Perez-Oliva A.B., Lachaud C., Szyniarowski P., Munoz I., Macartney T.,
RA   Hickson I., Rouse J., Alessi D.R.;
RT   "USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage
RT   responses.";
RL   EMBO J. 34:326-343(2015).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-21; LYS-37 AND LYS-243, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [16]
RP   INTERACTION WITH ERCC4, AND MUTAGENESIS OF ASP-221; LEU-223; MET-224;
RP   GLU-225; LEU-227 AND GLU-228.
RX   PubMed=32034146; DOI=10.1038/s41467-020-14564-x;
RA   Wang J., He H., Chen B., Jiang G., Cao L., Jiang H., Zhang G., Chen J.,
RA   Huang J., Yang B., Zhou C., Liu T.;
RT   "Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and
RT   activation.";
RL   Nat. Commun. 11:786-786(2020).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 96-227, X-RAY CRYSTALLOGRAPHY (2.7
RP   ANGSTROMS) OF 96-220-296 IN COMPLEX WIRH ERCC4, AND SUBUNIT.
RX   PubMed=16076955; DOI=10.1073/pnas.0504341102;
RA   Tsodikov O.V., Enzlin J.H., Scharer O.D., Ellenberger T.;
RT   "Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA
RT   structure-specific endonuclease XPF-ERCC1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:11236-11241(2005).
RN   [18]
RP   STRUCTURE BY NMR OF 220-297 IN COMPLEX WIRH ERCC4, AND SUBUNIT.
RX   PubMed=16338413; DOI=10.1016/j.str.2005.08.014;
RA   Tripsianes K., Folkers G., Ab E., Das D., Odijk H., Jaspers N.G.,
RA   Hoeijmakers J.H., Kaptein R., Boelens R.;
RT   "The structure of the human ERCC1/XPF interaction domains reveals a
RT   complementary role for the two proteins in nucleotide excision repair.";
RL   Structure 13:1849-1858(2005).
RN   [19]
RP   VARIANT COFS4 LEU-231, CHARACTERIZATION OF VARIANT COFS4 LEU-231, FUNCTION,
RP   AND SUBUNIT.
RX   PubMed=17273966; DOI=10.1086/512486;
RA   Jaspers N.G.J., Raams A., Silengo M.C., Wijgers N., Niedernhofer L.J.,
RA   Robinson A.R., Giglia-Mari G., Hoogstraten D., Kleijer W.J.,
RA   Hoeijmakers J.H.J., Vermeulen W.;
RT   "First reported patient with human ERCC1 deficiency has cerebro-oculo-
RT   facio-skeletal syndrome with a mild defect in nucleotide excision repair
RT   and severe developmental failure.";
RL   Am. J. Hum. Genet. 80:457-466(2007).
RN   [20]
RP   VARIANT COFS4 LEU-231, CHARACTERIZATION OF VARIANT COFS4 LEU-231, FUNCTION,
RP   AND INTERACTION WITH ERCC4.
RX   PubMed=23623389; DOI=10.1016/j.ajhg.2013.04.007;
RA   Kashiyama K., Nakazawa Y., Pilz D.T., Guo C., Shimada M., Sasaki K.,
RA   Fawcett H., Wing J.F., Lewin S.O., Carr L., Li T.S., Yoshiura K., Utani A.,
RA   Hirano A., Yamashita S., Greenblatt D., Nardo T., Stefanini M.,
RA   McGibbon D., Sarkany R., Fassihi H., Takahashi Y., Nagayama Y.,
RA   Mitsutake N., Lehmann A.R., Ogi T.;
RT   "Malfunction of nuclease ERCC1-XPF results in diverse clinical
RT   manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and
RT   Fanconi anemia.";
RL   Am. J. Hum. Genet. 92:807-819(2013).
CC   -!- FUNCTION: [Isoform 1]: Non-catalytic component of a structure-specific
CC       DNA repair endonuclease responsible for the 5'-incision during DNA
CC       repair. Responsible, in conjunction with SLX4, for the first step in
CC       the repair of interstrand cross-links (ICL). Participates in the
CC       processing of anaphase bridge-generating DNA structures, which consist
CC       in incompletely processed DNA lesions arising during S or G2 phase, and
CC       can result in cytokinesis failure. Also required for homology-directed
CC       repair (HDR) of DNA double-strand breaks, in conjunction with SLX4.
CC       {ECO:0000269|PubMed:17273966, ECO:0000269|PubMed:23623389,
CC       ECO:0000269|PubMed:24036546}.
CC   -!- FUNCTION: [Isoform 2]: Not functional in the nucleotide excision repair
CC       pathway. {ECO:0000305|PubMed:24036546}.
CC   -!- FUNCTION: [Isoform 3]: Not functional in the nucleotide excision repair
CC       pathway. {ECO:0000305|PubMed:24036546}.
CC   -!- FUNCTION: [Isoform 4]: Not functional in the nucleotide excision repair
CC       pathway. {ECO:0000305|PubMed:24036546}.
CC   -!- SUBUNIT: Heterodimer composed of ERCC1 isoform 1 and ERCC4/XPF
CC       (PubMed:16076955, PubMed:16338413, PubMed:24036546, PubMed:25538220,
CC       PubMed:32034146). Interacts with USP45 (PubMed:25538220).
CC       {ECO:0000269|PubMed:16076955, ECO:0000269|PubMed:16338413,
CC       ECO:0000269|PubMed:24036546, ECO:0000269|PubMed:25538220,
CC       ECO:0000269|PubMed:32034146}.
CC   -!- SUBUNIT: [Isoform 2]: Does not interact with ERCC4/XPF.
CC       {ECO:0000269|PubMed:24036546}.
CC   -!- SUBUNIT: [Isoform 3]: Does not interact with ERCC4/XPF.
CC       {ECO:0000269|PubMed:24036546}.
CC   -!- SUBUNIT: [Isoform 4]: Does not interact with ERCC4/XPF.
CC       {ECO:0000269|PubMed:24036546}.
CC   -!- INTERACTION:
CC       P07992; P00533: EGFR; NbExp=21; IntAct=EBI-750962, EBI-297353;
CC       P07992; Q92889: ERCC4; NbExp=13; IntAct=EBI-750962, EBI-2370770;
CC       P07992; Q13064: MKRN3; NbExp=3; IntAct=EBI-750962, EBI-2340269;
CC       P07992; Q6NSB6: MKRN3; NbExp=3; IntAct=EBI-750962, EBI-10195599;
CC       P07992; Q8IY92: SLX4; NbExp=6; IntAct=EBI-750962, EBI-2370740;
CC       P07992; Q96GJ1: TRMT2B; NbExp=3; IntAct=EBI-750962, EBI-10195625;
CC       P07992; Q96S82: UBL7; NbExp=4; IntAct=EBI-750962, EBI-348604;
CC       P07992; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-750962, EBI-739895;
CC       P07992; Q9H9H4: VPS37B; NbExp=4; IntAct=EBI-750962, EBI-4400866;
CC       P07992; P23025: XPA; NbExp=7; IntAct=EBI-750962, EBI-295222;
CC       P07992-3; O95995: GAS8; NbExp=3; IntAct=EBI-12699417, EBI-1052570;
CC       P07992-3; Q96S82: UBL7; NbExp=3; IntAct=EBI-12699417, EBI-348604;
CC       P07992-3; P23025: XPA; NbExp=3; IntAct=EBI-12699417, EBI-295222;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus
CC       {ECO:0000269|PubMed:24036546}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:24036546}. Nucleus {ECO:0000269|PubMed:24036546}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Nucleus
CC       {ECO:0000269|PubMed:24036546}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Nucleus
CC       {ECO:0000269|PubMed:24036546}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=202;
CC         IsoId=P07992-1; Sequence=Displayed;
CC       Name=2; Synonyms=203;
CC         IsoId=P07992-2; Sequence=VSP_042727;
CC       Name=3; Synonyms=201;
CC         IsoId=P07992-3; Sequence=VSP_043455;
CC       Name=4; Synonyms=204;
CC         IsoId=P07992-4; Sequence=VSP_053474;
CC   -!- PTM: Ubiquitinated with both 'Lys-48' and 'Lys-63' linkages
CC       (PubMed:25538220). Deubiquitinated by USP45 (PubMed:25538220).
CC       {ECO:0000269|PubMed:25538220}.
CC   -!- DISEASE: Cerebro-oculo-facio-skeletal syndrome 4 (COFS4) [MIM:610758]:
CC       A disorder of prenatal onset characterized by microcephaly, congenital
CC       cataracts, facial dysmorphism, neurogenic arthrogryposis, growth
CC       failure and severe psychomotor retardation. COFS is considered to be
CC       part of the nucleotide-excision repair disorders spectrum that include
CC       also xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome.
CC       {ECO:0000269|PubMed:17273966, ECO:0000269|PubMed:23623389}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the ERCC1/RAD10/SWI10 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/40481/ERCC1";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ercc1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M13194; AAA52394.1; -; mRNA.
DR   EMBL; M26163; AAA52395.1; -; Genomic_DNA.
DR   EMBL; M28650; AAA35810.1; -; mRNA.
DR   EMBL; AF001925; AAC16253.1; -; mRNA.
DR   EMBL; AB069681; BAB62810.1; -; mRNA.
DR   EMBL; BT019806; AAV38609.1; -; mRNA.
DR   EMBL; AF512555; AAM34796.1; -; Genomic_DNA.
DR   EMBL; AK092039; BAG52472.1; -; mRNA.
DR   EMBL; AK314884; BAG37398.1; -; mRNA.
DR   EMBL; AC092309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138128; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138534; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471126; EAW57349.1; -; Genomic_DNA.
DR   EMBL; BC008930; AAH08930.1; -; mRNA.
DR   EMBL; BC052813; AAH52813.1; -; mRNA.
DR   CCDS; CCDS12662.1; -. [P07992-1]
DR   CCDS; CCDS12663.1; -. [P07992-3]
DR   CCDS; CCDS54279.1; -. [P07992-2]
DR   PIR; A32875; A24781.
DR   RefSeq; NP_001159521.1; NM_001166049.1. [P07992-2]
DR   RefSeq; NP_001974.1; NM_001983.3. [P07992-1]
DR   RefSeq; NP_973730.1; NM_202001.2. [P07992-3]
DR   RefSeq; XP_005258691.1; XM_005258634.1.
DR   RefSeq; XP_005258692.1; XM_005258635.2.
DR   RefSeq; XP_005258693.1; XM_005258636.4.
DR   RefSeq; XP_011524912.1; XM_011526610.2.
DR   RefSeq; XP_016881948.1; XM_017026459.1.
DR   RefSeq; XP_016881949.1; XM_017026460.1.
DR   RefSeq; XP_016881950.1; XM_017026461.1.
DR   RefSeq; XP_016881951.1; XM_017026462.1.
DR   RefSeq; XP_016881952.1; XM_017026463.1.
DR   RefSeq; XP_016881953.1; XM_017026464.1.
DR   RefSeq; XP_016881954.1; XM_017026465.1.
DR   RefSeq; XP_016881955.1; XM_017026466.1.
DR   PDB; 1Z00; NMR; -; A=220-297.
DR   PDB; 2A1I; X-ray; 1.90 A; A=96-227.
DR   PDB; 2A1J; X-ray; 2.70 A; B=220-296.
DR   PDB; 2JNW; NMR; -; A=96-214.
DR   PDB; 2JPD; NMR; -; A=96-219.
DR   PDB; 2MUT; NMR; -; A=220-297.
DR   PDB; 6SXA; EM; 3.60 A; G=1-297.
DR   PDB; 6SXB; EM; 7.90 A; G=1-297.
DR   PDBsum; 1Z00; -.
DR   PDBsum; 2A1I; -.
DR   PDBsum; 2A1J; -.
DR   PDBsum; 2JNW; -.
DR   PDBsum; 2JPD; -.
DR   PDBsum; 2MUT; -.
DR   PDBsum; 6SXA; -.
DR   PDBsum; 6SXB; -.
DR   AlphaFoldDB; P07992; -.
DR   BMRB; P07992; -.
DR   SMR; P07992; -.
DR   BioGRID; 108379; 57.
DR   ComplexPortal; CPX-478; ERCC1-XPF endonuclease complex. [P07992-1]
DR   CORUM; P07992; -.
DR   DIP; DIP-24235N; -.
DR   IntAct; P07992; 26.
DR   MINT; P07992; -.
DR   STRING; 9606.ENSP00000013807; -.
DR   BindingDB; P07992; -.
DR   ChEMBL; CHEMBL3883316; -.
DR   iPTMnet; P07992; -.
DR   PhosphoSitePlus; P07992; -.
DR   BioMuta; ERCC1; -.
DR   DMDM; 119538; -.
DR   EPD; P07992; -.
DR   jPOST; P07992; -.
DR   MassIVE; P07992; -.
DR   MaxQB; P07992; -.
DR   PaxDb; P07992; -.
DR   PeptideAtlas; P07992; -.
DR   ProteomicsDB; 3611; -.
DR   ProteomicsDB; 52055; -. [P07992-1]
DR   ProteomicsDB; 52056; -. [P07992-2]
DR   ProteomicsDB; 52057; -. [P07992-3]
DR   Antibodypedia; 3826; 1468 antibodies from 44 providers.
DR   DNASU; 2067; -.
DR   Ensembl; ENST00000013807.9; ENSP00000013807.4; ENSG00000012061.16. [P07992-3]
DR   Ensembl; ENST00000300853.8; ENSP00000300853.3; ENSG00000012061.16. [P07992-1]
DR   Ensembl; ENST00000340192.11; ENSP00000345203.6; ENSG00000012061.16. [P07992-2]
DR   Ensembl; ENST00000423698.6; ENSP00000394875.2; ENSG00000012061.16. [P07992-4]
DR   Ensembl; ENST00000589165.5; ENSP00000468035.1; ENSG00000012061.16. [P07992-1]
DR   GeneID; 2067; -.
DR   KEGG; hsa:2067; -.
DR   MANE-Select; ENST00000300853.8; ENSP00000300853.3; NM_001983.4; NP_001974.1.
DR   UCSC; uc002pbs.3; human. [P07992-1]
DR   AGR; HGNC:3433; -.
DR   CTD; 2067; -.
DR   DisGeNET; 2067; -.
DR   GeneCards; ERCC1; -.
DR   GeneReviews; ERCC1; -.
DR   HGNC; HGNC:3433; ERCC1.
DR   HPA; ENSG00000012061; Low tissue specificity.
DR   MalaCards; ERCC1; -.
DR   MIM; 126380; gene.
DR   MIM; 610758; phenotype.
DR   neXtProt; NX_P07992; -.
DR   OpenTargets; ENSG00000012061; -.
DR   Orphanet; 90322; Cockayne syndrome type 2.
DR   Orphanet; 1466; COFS syndrome.
DR   PharmGKB; PA155; -.
DR   VEuPathDB; HostDB:ENSG00000012061; -.
DR   eggNOG; KOG2841; Eukaryota.
DR   GeneTree; ENSGT00390000011275; -.
DR   InParanoid; P07992; -.
DR   OMA; LNPDYIC; -.
DR   OrthoDB; 12065at2759; -.
DR   PhylomeDB; P07992; -.
DR   TreeFam; TF101231; -.
DR   PathwayCommons; P07992; -.
DR   Reactome; R-HSA-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   SignaLink; P07992; -.
DR   SIGNOR; P07992; -.
DR   BioGRID-ORCS; 2067; 103 hits in 1167 CRISPR screens.
DR   ChiTaRS; ERCC1; human.
DR   EvolutionaryTrace; P07992; -.
DR   GeneWiki; ERCC1; -.
DR   GenomeRNAi; 2067; -.
DR   Pharos; P07992; Tbio.
DR   PRO; PR:P07992; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P07992; protein.
DR   Bgee; ENSG00000012061; Expressed in apex of heart and 199 other tissues.
DR   ExpressionAtlas; P07992; baseline and differential.
DR   Genevisible; P07992; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070522; C:ERCC4-ERCC1 complex; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000109; C:nucleotide-excision repair complex; IDA:UniProtKB.
DR   GO; GO:0000110; C:nucleotide-excision repair factor 1 complex; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:UniProtKB.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IEA:Ensembl.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0001094; F:TFIID-class transcription factor complex binding; IEA:Ensembl.
DR   GO; GO:0008283; P:cell population proliferation; IEA:Ensembl.
DR   GO; GO:0008340; P:determination of adult lifespan; IEA:Ensembl.
DR   GO; GO:0006281; P:DNA repair; IMP:MGI.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:BHF-UCL.
DR   GO; GO:0048568; P:embryonic organ development; IEA:Ensembl.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0036297; P:interstrand cross-link repair; IEA:Ensembl.
DR   GO; GO:0045190; P:isotype switching; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0006312; P:mitotic recombination; IMP:UniProtKB.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:1905765; P:negative regulation of protection from non-homologous end joining at telomere; IMP:BHF-UCL.
DR   GO; GO:0032205; P:negative regulation of telomere maintenance; IMP:UniProtKB.
DR   GO; GO:0006289; P:nucleotide-excision repair; IDA:ComplexPortal.
DR   GO; GO:0048477; P:oogenesis; IEA:Ensembl.
DR   GO; GO:1904431; P:positive regulation of t-circle formation; ISS:BHF-UCL.
DR   GO; GO:0060261; P:positive regulation of transcription initiation by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0035166; P:post-embryonic hemopoiesis; IEA:Ensembl.
DR   GO; GO:0000720; P:pyrimidine dimer repair by nucleotide-excision repair; IEA:Ensembl.
DR   GO; GO:0090399; P:replicative senescence; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0009744; P:response to sucrose; IEA:Ensembl.
DR   GO; GO:0010165; P:response to X-ray; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0006949; P:syncytium formation; IEA:Ensembl.
DR   GO; GO:0090656; P:t-circle formation; ISS:BHF-UCL.
DR   GO; GO:0061819; P:telomeric DNA-containing double minutes formation; IMP:BHF-UCL.
DR   GO; GO:0009650; P:UV protection; IEA:Ensembl.
DR   GO; GO:0070914; P:UV-damage excision repair; IBA:GO_Central.
DR   CDD; cd22325; ERCC1_C-like; 1.
DR   Gene3D; 3.40.50.10130; -; 1.
DR   Gene3D; 1.10.150.20; 5' to 3' exonuclease, C-terminal subdomain; 1.
DR   IDEAL; IID00364; -.
DR   InterPro; IPR047260; ERCC1-like_central_dom.
DR   InterPro; IPR004579; ERCC1/RAD10/SWI10.
DR   InterPro; IPR011335; Restrct_endonuc-II-like.
DR   InterPro; IPR010994; RuvA_2-like.
DR   PANTHER; PTHR12749:SF0; DNA EXCISION REPAIR PROTEIN ERCC-1; 1.
DR   PANTHER; PTHR12749; EXCISION REPAIR CROSS-COMPLEMENTING 1 ERCC1; 1.
DR   Pfam; PF14520; HHH_5; 1.
DR   Pfam; PF03834; Rad10; 1.
DR   SUPFAM; SSF52980; Restriction endonuclease-like; 1.
DR   SUPFAM; SSF47781; RuvA domain 2-like; 1.
DR   TIGRFAMs; TIGR00597; rad10; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cataract; Cytoplasm;
KW   DNA damage; DNA repair; DNA-binding; Isopeptide bond; Nucleus;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..297
FT                   /note="DNA excision repair protein ERCC-1"
FT                   /id="PRO_0000087006"
FT   DNA_BIND        134..156
FT                   /evidence="ECO:0000255"
FT   REGION          1..39
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          220..297
FT                   /note="HhH2, dimerization with ERCC4/XPF"
FT                   /evidence="ECO:0000269|PubMed:16338413"
FT   MOTIF           17..23
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CROSSLNK        21
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        37
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        243
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         36..107
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053474"
FT   VAR_SEQ         235..258
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_042727"
FT   VAR_SEQ         282..297
FT                   /note="ARRLFDVLHEPFLKVP -> VRALGKNPRSWGKERAPNKHNLRPQSFKVKKE
FT                   PKTRHSGFRL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043455"
FT   VARIANT         231
FT                   /note="F -> L (in COFS4; does not alter interaction with
FT                   ERCC4/XPF; dbSNP:rs121913028)"
FT                   /evidence="ECO:0000269|PubMed:17273966,
FT                   ECO:0000269|PubMed:23623389"
FT                   /id="VAR_032776"
FT   VARIANT         266
FT                   /note="A -> T (in dbSNP:rs3212977)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_019167"
FT   MUTAGEN         221
FT                   /note="D->A: Impaired interaction with ERCC4."
FT                   /evidence="ECO:0000269|PubMed:32034146"
FT   MUTAGEN         223
FT                   /note="L->A: Impaired interaction with ERCC4."
FT                   /evidence="ECO:0000269|PubMed:32034146"
FT   MUTAGEN         224
FT                   /note="M->A: Impaired interaction with ERCC4."
FT                   /evidence="ECO:0000269|PubMed:32034146"
FT   MUTAGEN         225
FT                   /note="E->A: Impaired interaction with ERCC4."
FT                   /evidence="ECO:0000269|PubMed:32034146"
FT   MUTAGEN         227
FT                   /note="L->A: Impaired interaction with ERCC4."
FT                   /evidence="ECO:0000269|PubMed:32034146"
FT   MUTAGEN         228
FT                   /note="E->A: Impaired interaction with ERCC4."
FT                   /evidence="ECO:0000269|PubMed:32034146"
FT   CONFLICT        53
FT                   /note="A -> P (in Ref. 6; BAG37398)"
FT                   /evidence="ECO:0000305"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   HELIX           105..107
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   HELIX           111..115
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   STRAND          121..123
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   STRAND          127..133
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   STRAND          136..142
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   HELIX           143..148
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   HELIX           152..160
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   STRAND          163..172
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   HELIX           179..192
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   STRAND          195..201
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   HELIX           202..213
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   HELIX           222..226
FT                   /evidence="ECO:0007829|PDB:2A1I"
FT   STRAND          242..244
FT                   /evidence="ECO:0007829|PDB:1Z00"
FT   HELIX           247..257
FT                   /evidence="ECO:0007829|PDB:2A1J"
FT   HELIX           260..264
FT                   /evidence="ECO:0007829|PDB:2A1J"
FT   HELIX           268..272
FT                   /evidence="ECO:0007829|PDB:2A1J"
FT   STRAND          274..276
FT                   /evidence="ECO:0007829|PDB:2A1J"
FT   HELIX           280..290
FT                   /evidence="ECO:0007829|PDB:2A1J"
FT   STRAND          293..295
FT                   /evidence="ECO:0007829|PDB:1Z00"
SQ   SEQUENCE   297 AA;  32562 MW;  6FCE3615732349E5 CRC64;
     MDPGKDKEGV PQPSGPPARK KFVIPLDEDE VPPGVAKPLF RSTQSLPTVD TSAQAAPQTY
     AEYAISQPLE GAGATCPTGS EPLAGETPNQ ALKPGAKSNS IIVSPRQRGN PVLKFVRNVP
     WEFGDVIPDY VLGQSTCALF LSLRYHNLHP DYIHGRLQSL GKNFALRVLL VQVDVKDPQQ
     ALKELAKMCI LADCTLILAW SPEEAGRYLE TYKAYEQKPA DLLMEKLEQD FVSRVTECLT
     TVKSVNKTDS QTLLTTFGSL EQLIAASRED LALCPGLGPQ KARRLFDVLH EPFLKVP
//
